Diversity in Alzheimer's disease drug trials: The importance of eligibility criteria-Reference-Cited by-同舟云学术

Diversity in Alzheimer's disease drug trials: The importance of eligibility criteria

Published:2021-09-30 Issue: Volume: Page:
ISSN:1552-5260
Container-title:Alzheimer's & Dementia
language:en
Short-container-title:Alzheimer's & Dementia

Author:

Franzen Sanne¹,Smith Jade Emily¹,den Berg Esther¹,Rivera Mindt Monica²³,Bruchem‐Visser Rozemarijn L.⁴,Abner Erin L.⁵⁶⁷,Schneider Lon S.⁸,Prins Niels D.⁹¹⁰,Babulal Ganesh M.¹¹¹²,Papma Janne M.¹

Affiliation:

1. Department of Neurology Erasmus MC University Medical Center Rotterdam the Netherlands

2. Department of Psychology and Latin American Latino Studies Institute Fordham University The Bronx New York USA

3. Department of Neurology The Icahn School of Medicine at Mount Sinai New York New York USA

4. Department of Internal Medicine Erasmus MC University Medical Center Rotterdam the Netherlands

5. Sanders‐Brown Center on Aging and Alzheimer's Disease Center University of Kentucky Lexington Kentucky USA

6. College of Public Health Department of Epidemiology University of Kentucky Lexington Kentucky USA

7. College of Public Health Department of Biostatistics University of Kentucky Lexington Kentucky USA

8. Keck School of Medicine of the University of Southern California Los Angeles California USA

9. Alzheimer Center Department of Neurology VU University Medical Center Amsterdam the Netherlands

10. Brain Research Center Amsterdam the Netherlands

11. Department of Neurology and Knight Alzheimer's Disease Research Center Washington University School of Medicine St. Louis Missouri USA

12. Department of Psychology University of Johannesburg Johannesburg South Africa

Funder

National Science Foundation

National Institutes of Health

BrightFocus Foundation

Alzheimer's Association

Publisher

Wiley

Subject

Psychiatry and Mental health,Cellular and Molecular Neuroscience,Geriatrics and Gerontology,Neurology (clinical),Developmental Neuroscience,Health Policy,Epidemiology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/alz.12433

Reference81 articles.

1. 2015 Alzheimer's disease facts and figures;Alzheimer's Association;Alzheimers Dement,2015

2. Alzheimer’s Disease In African Americans: Risk Factors And Challenges For The Future

3. The global prevalence of dementia: A systematic review and metaanalysis

4. Migration and dementia: A meta‐analysis of epidemiological studies in Europe;Selten J‐P;Psychol Med,2020

5. Race reporting and disparities in clinical trials on Alzheimer’s disease: A systematic review

Cited by 66 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The ADNI4 Digital Study: A novel approach to recruitment, screening, and assessment of participants for AD clinical research;Alzheimer's & Dementia;2024-09

2. Story recall performance and AT classification via positron emission tomography: A comparison of logical memory and Craft Story 21;Journal of the Neurological Sciences;2024-09

3. Community recruitment of underrepresented populations to the AHEAD 3‐45 preclinical AD trial using novel partnerships with nursing and community‐based organizations: Lessons and outcomes;Alzheimer's & Dementia;2024-08-29

4. Rationale and design of the BeyeOMARKER study: prospective evaluation of blood- and eye-based biomarkers for early detection of Alzheimer’s disease pathology in the eye clinic;Alzheimer's Research & Therapy;2024-08-21

5. A Protocol for the Inclusion of Minoritized Persons in Alzheimer Disease Research From the ADNI3 Diversity Taskforce;JAMA Network Open;2024-08-09